Status and phase
Conditions
Treatments
About
A community-based, open-label, cluster-randomised longitudinal study in which children are randomized according to village health worker catchment areas comparing the safety and effectiveness of repeated treatments with artemether-lumefantrine (AL) over a 3-year period in children 4-48 months to that of repeated treatment with dihydroartemisinin-piperaquine (DHA-PPQ).
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1,200 participants in 2 patient groups
Loading...
Central trial contact
David Lalloo, MD; Kamija Phiri, MD PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal